Does BENDAMUSTINE Cause Myelodysplastic syndrome? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Myelodysplastic syndrome have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 1.2% of all adverse event reports for BENDAMUSTINE.
229
Reports of Myelodysplastic syndrome with BENDAMUSTINE
1.2%
of all BENDAMUSTINE reports
54
Deaths
75
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From BENDAMUSTINE?
Of the 229 reports, 54 (23.6%) resulted in death, 75 (32.8%) required hospitalization, and 38 (16.6%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
Yes, Myelodysplastic syndrome is listed as a known adverse reaction in the official FDA drug label for BENDAMUSTINE.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which BENDAMUSTINE Alternatives Have Lower Myelodysplastic syndrome Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE